-
India's total active caseload has decreased to 37,04,893 today.
-
The study led by University of Oxford researchers, earlier this year, began to investigate the effect of alternate doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine.
-
The imported doses of the vaccine are presently priced at Rs 995 (Rs 948 plus 5 per cent GST per dose), with the possibility of a lower price point when local supply begins.
-
Terms data as strategic ammunition available for managing the pandemic
-
On Tuesday, Health Minister Rajesh Tope had alleged that the Union government was not fulfilling its responsibility to provide adequate number of vaccine doses to states.
-
The Chief Minister gave a set of directions to the officials including resolving the confusion over vaccine availability, oxygen supply in districts and ICU beds, according to an official release.
-
The chief minister urged the Centre to provide it 85 lakh doses per month so that all the Delhiites could be vaccinated in the next three months.
-
He lauded the High Courts and the Supreme Court for commenting seriously and asking the Governments about the steps they were taking to help the people.
-
The Phase 2b randomised, observer-blinded, placebo-controlled trial conducted in South Africa evaluated efficacy, safety and immunogenicity in healthy adults, and in a small cohort of medically stable adults
-
The cumulative number of COVID-19 vaccine doses administered in the country has crossed 16.49 crore.
-
Majority of private hospitals, who were facing difficulties in sourcing vaccines, expected to launch drive in the next few days
-
Initiatives aimed at early detection and treatment of corona patients; people found with symptoms to be given Covid kits
-
Due to challenges in production and sheer demand, almost all major vaccine manufacturing companies in Hyderabad and elsewhere in the country are busy delivering their Covid vaccine commitments made for the month of May, after which vaccine availability could improve.
-
Of the 65,551 beneficiaries, 47,481 persons received the first dose of the vaccine while 18,070 received the second dose
-
When the ANM Manjula and Mallishwari, a health worker and other staff replied that there was no vaccination stock at the centre, Rajesh got angry and began abusing and assaulting them.
-
The ministry said 6,71,285 beneficiaries in the age group of 18-44 years have received their first dose of COVID vaccine across 12 states and UTs.
-
By early next week, the company is expected to get FDA approval for emergency use of its vaccine in children 12 to 15 years old.
-
The Covid vaccines will not be available at private CVCs and for individuals who plan to walk in at the vaccination centres.
-
The N440K can generate about ten times more virus particles than the A2a prototype, the strain which is in circulation worldwide
-
Registration for the newly eligible population groups had commenced on April 28.